Answers are grounded in this paper and cite their sources.
Purpose In vitro gametogenesis (IVG) has the potential to transform assisted reproduction by generating functional gametes from pluripotent stem cells and expanding access to genetic parenthood. However, a less explored consequence is its potential to enable the production of hundreds of embryos, fundamentally changing the scale and nature of embryo selection. This paper examines how such “embryo abundance” could intensify existing ethical concerns surrounding preimplantation genetic testing, polygenic embryo screening, and artificial intelligence-driven embryo ranking. Methods This paper presents a conceptual and ethical analysis of the implications of large-scale embryo production and selection enabled by IVG, focusing on reproductive autonomy, disability, procreative beneficence, inequality, and the commercialisation of reproductive medicine. Results Increasing the number of embryos available for selection may shift reproductive decision-making from therapeutic medicine towards reproductive optimization, creating new pressures to select the perceived “best” embryo. As selection becomes increasingly technologically feasible and socially normalized, reproductive choice may paradoxically evolve into expectations of reproductive responsibility. Conclusions IVG requires anticipatory ethical and regulatory consideration extending beyond questions of safety and access. Governance must address not only whether IVG can be introduced safely, but also how large-scale embryo selection may reshape understandings of reproductive autonomy, human variation, and responsible parenthood.
No takes yet. Share an insight, caveat, or question.
Choong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: